A patient with confirmed lactose malabsorption and mild hypokalemia is experiencing gastrointestinal discomfort and has been found to have occult blood in the stool. What is the most appropriate initial nursing intervention to address the patient's electrolyte imbalance?

B) Administer oral rehydration solutions as ordered to correct the electrolyte imbalance.

A) Restrict the patient's fluid intake to prevent further electrolyte loss.

B) Administer oral rehydration solutions as ordered to correct the electrolyte imbalance.

C) Encourage a high-fiber diet to manage gastrointestinal symptoms.

D) Initiate a lactose-free diet immediately to prevent further malabsorption.

A patient with confirmed lactose malabsorption also presents with mild hypokalemia and stool positive for occult blood. Which nursing intervention is most appropriate to address the patient's current condition and prevent further complications?

B) Administer potassium supplements and oral rehydration solutions as ordered.

A) Encourage a high-fiber diet to enhance bowel movements.

B) Administer potassium supplements and oral rehydration solutions as ordered.

C) Increase dairy intake to improve calcium absorption.

D) Restrict fluid intake to prevent further electrolyte imbalance.

A patient with newly diagnosed mild to moderate ulcerative colitis is experiencing worsening abdominal pain, bloating, and electrolyte disturbances with a potassium level of 3.0 mEq/L. Which nursing intervention is the highest priority to address the patient's current condition?

C) Monitor vital signs and prepare for potential IV fluid therapy.

A) Administer oral potassium supplements as prescribed.

B) Initiate a low-residue diet to reduce bowel activity.

C) Monitor vital signs and prepare for potential IV fluid therapy.

D) Educate the patient on the importance of medication adherence for ulcerative colitis.

A patient with a recent diagnosis of mild to moderate ulcerative colitis presents with increased abdominal pain, bloating, and electrolyte imbalances. Which nursing intervention is most appropriate to address the patient's current complications and support their treatment plan?

B) Administer prescribed anti-inflammatory medication and monitor for side effects

A) Encourage a high-fiber diet to promote bowel regularity

B) Administer prescribed anti-inflammatory medication and monitor for side effects

C) Increase oral fluid intake to address electrolyte imbalances

D) Recommend complete bed rest to reduce abdominal pain

A patient with ulcerative colitis is experiencing persistent fatigue and generalized weakness, with lab results indicating a hemoglobin level of 9.8 g/dL. Which nursing intervention is most appropriate to address the underlying cause of these symptoms?

A) Administer iron supplements as prescribed to address potential iron-deficiency anemia.

B) Encourage increased fluid intake to manage dehydration associated with diarrhea.

C) Initiate corticosteroid therapy to reduce colonic inflammation and enhance absorption.

D) Recommend a high-fiber diet to promote gastrointestinal health and improve energy levels.

A patient with ulcerative colitis is being treated with mesalamine and corticosteroids. Despite improvement in her symptoms, she now presents with fatigue and generalized weakness, and her hemoglobin level is 9.8 g/dL. Which nursing intervention should be prioritized to address her current symptoms and overall condition?

B) Initiate iron supplementation to address potential iron-deficiency anemia.

A) Increase her corticosteroid dosage to reduce inflammation and improve energy levels.

B) Initiate iron supplementation to address potential iron-deficiency anemia.

C) Encourage a high-residue diet to increase nutrient absorption.

D) Recommend complete bed rest to conserve energy and prevent further fatigue.

A patient with hypokalemia and anemia is experiencing increased palpitations and shortness of breath during light activities. The nurse understands that which of the following interventions is most crucial to stabilize the patient's cardiac status?

C) Increase the frequency and dosage of intravenous potassium.

A) Initiate a high-sodium diet to improve fluid balance.

B) Administer oral potassium supplements immediately.

C) Increase the frequency and dosage of intravenous potassium.

D) Encourage the patient to perform daily aerobic exercises.

A patient with a history of ulcerative colitis and lactose intolerance is experiencing increased palpitations and shortness of breath. Her recent diagnoses include hypokalemia and anemia. Given her current symptoms and lab results, which intervention should the nurse prioritize to address her condition?

B) Increase the frequency and dosage of intravenous potassium to stabilize electrolyte levels.

A) Administer oral potassium supplements to correct hypokalemia.

B) Increase the frequency and dosage of intravenous potassium to stabilize electrolyte levels.

C) Encourage the patient to consume a potassium-rich diet to improve her symptoms.

D) Initiate oral iron supplements to correct the anemia.

A patient with hypomagnesemia and hypokalemia is experiencing persistent tachycardia and hypotension despite treatment. Which adjustment in the treatment plan is most likely to stabilize the patient's cardiac status?

B) Administer intravenous magnesium sulfate.

A) Increase oral potassium supplementation.

B) Administer intravenous magnesium sulfate.

C) Initiate a beta-blocker to manage tachycardia.

D) Provide a high-sodium diet to improve blood pressure.

lactose intolerance - Nursing Case Study

Pathophysiology

• Primary mechanism: Lactose intolerance primarily results from a deficiency of lactase, the enzyme responsible for hydrolyzing lactose into glucose and galactose in the small intestine. This deficiency can be due to a genetic reduction in lactase production after weaning, leading to malabsorption of lactose.

• Secondary mechanism: Unabsorbed lactose in the intestinal lumen undergoes fermentation by colonic bacteria, producing short-chain fatty acids and gases like hydrogen, methane, and carbon dioxide. This fermentation process contributes to the characteristic symptoms of bloating, flatulence, and abdominal pain.

• Key complication: The osmotic effect of undigested lactose draws water into the intestinal lumen, potentially causing diarrhea and contributing to dehydration and electrolyte imbalance if not managed properly, emphasizing the need for dietary modifications and symptom management in affected individuals.

Patient Profile

Demographics:

35-year-old female, software engineer

History:

• Key past medical history: Diagnosed with lactose intolerance 2 years ago, history of irritable bowel syndrome (IBS)

• Current medications: Lactase enzyme supplement as needed, probiotics daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased gastrointestinal discomfort despite dietary modifications

• Key symptoms: Abdominal pain, bloating, diarrhea, occasional nausea, fatigue

• Vital signs: Blood pressure 145/90 mmHg, heart rate 95 bpm, respiratory rate 20 breaths per minute, temperature 98.9°F

Section 1

New Diagnostic Results:

The patient underwent a series of diagnostic tests to further investigate the cause of her increasing gastrointestinal discomfort. A hydrogen breath test was performed to measure the levels of hydrogen and methane gases, which are elevated in cases of lactose malabsorption. Results indicated a significant rise in hydrogen levels post-lactose ingestion, confirming persistent lactose malabsorption. Additionally, a comprehensive metabolic panel revealed mild hypokalemia, with a potassium level of 3.3 mEq/L, likely due to ongoing diarrhea and subsequent electrolyte loss. Serum calcium and magnesium levels were within normal limits, but the presence of mild hypokalemia suggests a need for electrolyte management.

Stool analysis showed the presence of fatty acids, reinforcing the suspicion of malabsorption. As a secondary finding, the stool sample tested positive for occult blood, prompting further investigation to rule out other gastrointestinal disorders potentially exacerbating her symptoms. These results, coupled with her elevated blood pressure and heart rate, suggest that her body is under stress, potentially from dehydration and electrolyte imbalance.

These diagnostic results indicate the necessity for a more comprehensive approach to her management. The presence of occult blood in the stool raises the possibility of another underlying condition, such as small intestinal bacterial overgrowth (SIBO) or inflammatory bowel disease (IBD), which could be complicating her lactose intolerance and IBS. The healthcare team is considering additional investigations, such as a colonoscopy or small bowel imaging, to identify any other potential sources of gastrointestinal bleeding. Meanwhile, the patient will be advised to continue her probiotics and lactase supplements, with the addition of oral rehydration solutions to address her electrolyte imbalance and mitigate the risk of further complications.

Section 2

New Complications:

Despite initial management efforts, the patient began experiencing worsening symptoms, prompting further evaluation. She reported increased abdominal pain and bloating, along with a significant increase in the frequency and urgency of her diarrhea. Her vital signs revealed a blood pressure of 152/90 mmHg, heart rate of 102 bpm, and a temperature of 99.1°F, suggesting a systemic inflammatory response. Clinical examination revealed diffuse abdominal tenderness, particularly in the lower quadrants, with no rebound tenderness or guarding.

Laboratory tests indicated further electrolyte disturbances, with her potassium level dropping to 3.0 mEq/L despite oral rehydration efforts. Her serum albumin level was also slightly decreased at 3.2 g/dL, indicative of potential protein-losing enteropathy. Given these developments, the healthcare team considered the possibility of an exacerbation of an undiagnosed inflammatory bowel condition, contributing to her malabsorption and worsening symptoms. The presence of occult blood in the stool, coupled with her deteriorating clinical status, warranted urgent endoscopic evaluation to determine the underlying cause and guide further management.

The decision was made to proceed with a colonoscopy, which revealed patchy areas of inflammation and superficial ulcerations in the colonic mucosa, consistent with a diagnosis of mild to moderate ulcerative colitis. Biopsy samples were taken for histopathological analysis to confirm the diagnosis and assess the severity of inflammation. This new complication necessitates a shift in her treatment strategy, including the introduction of anti-inflammatory medications to control the colitis, alongside continuing management for her lactose intolerance and electrolyte imbalance. The clinical team will closely monitor her response to these interventions, adjusting the treatment plan based on her evolving clinical needs.

Section 3

As the healthcare team initiated treatment for the newly diagnosed ulcerative colitis, the patient was started on mesalamine, an anti-inflammatory medication designed to reduce colonic inflammation. Additionally, corticosteroids were considered for more rapid control of her symptoms, given the severity of her flare-up. Electrolyte replenishment was intensified, with intravenous potassium supplementation initiated to address her persistent hypokalemia, which had dropped further to 2.8 mEq/L, posing a risk for cardiac arrhythmias. Her nutritional status was closely monitored, with dietary adjustments implemented to account for both her lactose intolerance and the need for a low-residue diet to minimize bowel irritation.

Over the following days, the patient began to show signs of clinical stabilization. Her abdominal pain and bloating gradually decreased, and the frequency of her diarrhea lessened. Vital signs began to normalize, with her blood pressure reducing to 138/86 mmHg and heart rate stabilizing at 88 bpm. However, her serum albumin remained low at 3.0 g/dL, indicating ongoing protein loss, likely due to the colitis. This prompted the interdisciplinary team to involve a dietitian to optimize her nutritional intake, focusing on high-protein, easily digestible foods to support mucosal healing and overall recovery.

Despite these improvements, the patient developed a new complication: persistent fatigue and generalized weakness, which raised concerns for anemia, a common complication in inflammatory bowel disease due to chronic inflammation and possible gastrointestinal blood loss. A complete blood count revealed a hemoglobin level of 9.8 g/dL, suggesting mild anemia. This new finding required further workup to determine the cause and appropriate management. The team considered iron supplementation and potential adjustments in her medication regimen, emphasizing the importance of continued monitoring and a holistic approach to her complex clinical picture. The patient's journey would now focus on addressing her anemia while maintaining control of her colitis and managing her lactose intolerance, highlighting the intricate interplay of her multiple health challenges.

Section 4

As the healthcare team continued to monitor the patient's progress, they noted a change in her status that required immediate attention. Despite initial improvement, the patient began experiencing increased palpitations and shortness of breath, particularly during light physical activities such as walking to the bathroom. Vital signs revealed a resting heart rate that had risen to 110 bpm, and further evaluation showed an irregular heartbeat. These symptoms, coupled with her persistent fatigue, prompted a closer examination of her electrolyte status and cardiac function, given her recent hypokalemia and anemia diagnosis.

A repeat electrolyte panel was performed, revealing that her serum potassium remained low at 3.1 mEq/L, indicating that the current supplementation regimen was insufficient. This electrolyte imbalance, combined with her anemia, likely contributed to her new cardiac symptoms. An electrocardiogram (ECG) was ordered to assess for arrhythmias, revealing premature ventricular contractions (PVCs), a finding consistent with both hypokalemia and anemia. These developments necessitated an adjustment in her potassium supplementation, with an increase in the frequency and dosage of intravenous potassium, as well as consideration of oral supplementation once her gastrointestinal symptoms stabilized.

The interdisciplinary team also revisited her anemia management plan. Given the likelihood of both chronic disease and iron deficiency contributing to her low hemoglobin, intravenous iron therapy was initiated to expedite correction of her anemia and mitigate her symptomatic palpitations. The team remained vigilant in monitoring her cardiac rhythm and overall response to the interventions, recognizing the necessity of integrating care for her multifaceted conditions. This phase of her treatment would focus on stabilizing her cardiac status while continuing to manage her ulcerative colitis and lactose intolerance, underscoring the need for meticulous coordination across specialties to ensure comprehensive care.

Section 5

As the healthcare team continued to monitor the patient’s response to the revised treatment plan, they observed a concerning change in her status. Despite efforts to correct her electrolyte imbalance and anemia, the patient began experiencing new symptoms, including increased frequency of palpitations and worsening shortness of breath even at rest. Her vital signs indicated a persistent tachycardia with a heart rate of 120 bpm, and her blood pressure had dropped to 95/60 mmHg. This hypotensive episode, coupled with her tachycardia and continued fatigue, necessitated an urgent re-evaluation of her condition.

A new set of diagnostic tests was performed to further investigate the underlying causes of her deteriorating status. A comprehensive metabolic panel revealed that her serum magnesium level was low at 1.4 mg/dL, in addition to her persistently low potassium level of 3.0 mEq/L. The team recognized that hypomagnesemia could exacerbate her cardiac symptoms and contribute to the refractory nature of her hypokalemia. Additionally, a repeat complete blood count showed that her hemoglobin had not improved significantly, maintaining at 9.0 g/dL, indicating a continued struggle with her anemia despite the initiation of iron therapy.

In light of these findings, the team promptly adjusted her treatment plan. Intravenous magnesium sulfate was added to her regimen to address the hypomagnesemia, with careful monitoring of her cardiac rhythm and serum electrolyte levels. The approach to her anemia was reassessed, considering the potential need for a blood transfusion if her symptoms did not improve. The interdisciplinary team remained closely involved, ensuring that all aspects of her care were tailored to address the interplay between her electrolyte imbalances, anemia, and cardiac function. This phase of treatment highlighted the importance of comprehensive management and vigilance as they worked to stabilize her condition and prevent further complications.